Press "Enter" to skip to content

Strides board approves USD 15 mn investment in Stelis Biopharma

The company’s board has approved participation in the Series B fundraiser of Stelis Biopharma with a commitment of USD 15 million, Strides Pharma Science said in a regulatory filing.

Original source:

Also Read:   Covaxin trials for kids likely soon in Nagpur